View Author
scopus: 7005136167

Corti, R.

(Roberto Corti)


stent patient lesion score vessel group trial angiographic syntax score study outcome sirolimus-eluting syntax death diameter disease follow-up acef score biolimus-eluting month polymer event value thrombosis percutaneou artery 9 months ͻ0.001 table sxscore sirolimus-eluting stent infarction analysis stenosi cardiology leader revascularization stent thrombosis artery disease number tertile biolimus-eluting stent intervention population procedure target 360 days treatment swets subscription service switzerland sirolimus-eluting stent group characteristic all-comer drug-eluting sirolimu biolimus-eluting stent group sirolimus-eluting stents drug-eluting stents hospital angiographic follow-up result in-stent biolimu wykrzykowska netherland university ratio endpoint e fficacy lumen diameter department bern university hospital lumen point target lesion revascularization september end points vessel size stent implantation model




4 Most Recent Publications

Value of age, creatinine, and ejection fraction (acef score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS Trial (Article)
Wykrzykowska, J.J. Garg, S.A. Klauss, V. Corti, R. Eberli, F.R. Wijns, W. Morice, M-C. Mario, C. di Geuns, R-J.M. van Jùni, P. Windecker, S. Serruys, P.W.J.C. Onuma, Y. Vries, A. de Goedhart, D. Morel, M-A.M. Es, E.-A. van Buszman, P. Linke, A. Ischinger, T.
2011-02-01
Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (limus eluted from a durable versus ERodable stent coating) trial (Article)
Wykrzykowska, J.J. Garg, S.A. Corti, R. Eberli, F.R. Wijns, W. Morice, M-C. Mario, C. di Geuns, R-J.M. van Juni, P. Windecker, S. Serruys, P.W.J.C. Girasis, C. Vries, T. de Morel, M-A.M. Es, G.A. van Buszman, P. Linke, A. Ischinger, T. Klauss, V.
2010-07-20
Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization With Biolimus-Eluting Stent With Biodegradable Polymer and Sirolimus-Eluting Stent With Durable Polymer. The LEADERS Trial Substudy (Article)
Wykrzykowska, J.J. Serruys, P.W.J.C. Eberli, F.R. Wijns, W. Morice, M-C. Mario, C. di Geuns, R-J.M. van Jùni, P. Windecker, S. Onuma, Y. Vries, A. de Es, G.A. van Buszman, P. Linke, A. Ischinger, T. Klauss, V. Corti, R.
2009-09-01
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial (Article)
Windecker, S. Serruys, P.W.J.C. Corti, R. Wijns, W. Morice, M-C. Mario, C. di Davies, S. Geuns, R-J.M. van Eerdmans, P. Es, G.A. van Meier, B. Jùni, P. Wandel, S. Buszman, P. Trznadel, S. Linke, A. Lenk, K. Ischinger, T. Klauss, V. Eberli, F.R.
2008-09-01